Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer - Related Studies

Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00080743. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer

2	Additional conditions recognized in this trial
		Breast Neoplasms

3	More general conditions related to this trial
		Breast Diseases
		Neoplasms
		Neoplasms by Site
		Skin Diseases

4	Interventions listed in this trial
		gefitinib
		tamoxifen citrate

5	Additional drug interventions recognized in this trial
		Tamoxifen

6	More general drug interventions related to this trial
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Bone Density Conservation Agents
		Enzyme Inhibitors
		Estrogen Antagonists
		Estrogen Receptor Modulators
		Hormone Antagonists
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protein Kinase Inhibitors
		Selective Estrogen Receptor Modulators
		Therapeutic Uses

7	Sponsors listed in this trial
		Norris Cotton Cancer Center
		National Cancer Institute (NCI)